Jochen H. Lorch
Impact in
- Otorhinolaryngology top 0.1%
- Head and Neck Cancer Studies
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Polyomavirus and related diseases
- Cancer-related Molecular Pathways
- CAR-T cell therapy research
Papers in
-
- Head and Neck Cancer Studies 28
-
- Thyroid Cancer Diagnosis and Treatment 30
- Co-authors
- Robert I. Haddad (47 shared papers)Marshall R. Posner (17 shared papers)Nicholas J. Sarlis (5 shared papers)Roy B. Tishler (28 shared papers)Glenn J. Hanna (24 shared papers)Olga G. Goloubeva (4 shared papers)Kevin J. Cullen (4 shared papers)Anja von Heydebreck (2 shared papers)
- Journals
- Oral Oncology (11 papers)International Journal of Radiation Oncology*Biology*Physics (7 papers)Head & Neck (6 papers)Clinical Cancer Research (6 papers)The Oncologist (6 papers)
- Partner nations
- United StatesFranceGermany
In The Last Decade
Jochen H. Lorch
105 papers receiving 8.2k citations
Jochen H. Lorch's Hit Papers
Peers
Comparison fields: 5 of 119
- Otorhinolaryngology 2.0k
- Oncology 3.7k
- Endocrinology, Diabetes and Metabolism 945
- Cancer Research 724
- Immunology 968
Countries citing papers authored by Jochen H. Lorch
This map shows the geographic impact of Jochen H. Lorch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jochen H. Lorch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jochen H. Lorch more than expected).
Fields of papers citing papers by Jochen H. Lorch
This network shows the impact of papers produced by Jochen H. Lorch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jochen H. Lorch. The network helps show where Jochen H. Lorch may publish in the future.
Co-authors
The 25 scholars most cited alongside Jochen H. Lorch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial Hit paper breakdown → | 2016 | 1024 |
| 2 | CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation Hit paper breakdown → | 2017 | 619 |
| 3 | Efficacy of Selpercatinib in RET -Altered Thyroid Cancers Hit paper breakdown → | 2020 | 589 |
| 4 | Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial Hit paper breakdown → | 2013 | 551 |
| 5 | Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids Hit paper breakdown → | 2017 | 484 |
| 6 | Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial Hit paper breakdown → | 2011 | 387 |
| 7 | Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial Hit paper breakdown → | 2011 | 351 |
| 8 | Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma Hit paper breakdown → | 2020 | 285 |
| 9 | 2014 | 268 | |
| 10 | 2018 | 261 | |
| 11 | 2009 | 246 | |
| 12 | 2015 | 237 | |
| 13 | 2018 | 226 | |
| 14 | 2013 | 149 | |
| 15 | 2020 | 128 | |
| 16 | 2004 | 126 | |
| 17 | 2010 | 99 | |
| 18 | 2018 | 99 | |
| 19 | 2021 | 89 | |
| 20 | 2020 | 87 |
About Jochen H. Lorch
Jochen H. Lorch is a scholar working on Otorhinolaryngology, Endocrinology, Diabetes and Metabolism, Oncology, Genetics and Surgery, having authored 110 papers that have together received 8.3k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (30 papers), Head and Neck Cancer Studies (28 papers), Salivary Gland Tumors Diagnosis and Treatment (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), BRCA gene mutations in cancer (8 papers), Polyomavirus and related diseases (5 papers), Ear and Head Tumors (5 papers) and Cancer-related Molecular Pathways (5 papers). The work is most often cited by research in Otorhinolaryngology (2.0k citations), Oncology (3.7k citations), Endocrinology, Diabetes and Metabolism (945 citations), Cancer Research (724 citations) and Immunology (968 citations). Jochen H. Lorch has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Robert I. Haddad, Marshall R. Posner, Nicholas J. Sarlis, Roy B. Tishler, Glenn J. Hanna, Olga G. Goloubeva, Kevin J. Cullen, Anja von Heydebreck, Howard L. Kaufman and Célèste Lebbé. Their work appears in journals such as Oral Oncology, International Journal of Radiation Oncology*Biology*Physics, Head & Neck, Clinical Cancer Research and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.